Senate approves coverage requirement for exome testing for certain Medicaid and public‑employee enrollees

The Utah Senate approved First Substitute House Bill 435, a measure requiring the state Medicaid program and the Public Employees Benefit and Insurance Program to cover exome‑sequence testing for certain enrollees with suspected or undiagnosed rare genetic conditions.

Senator Buxton, sponsor of the bill, told the chamber the bill defines terms and requires the state programs to cover exome sequencing for eligible enrollees, arguing the coverage would help people with rare and often under‑diagnosed conditions who currently lack access to appropriate testing and diagnosis coordination.

“Basically, you have some people that are covered or should be covered in the insurance that have very rare, rare, rare diseases that are not covered,” Buxton said during her presentation, describing the change as an effort to help such enrollees and to coordinate with others who have faced similar problems.

The Senate voted under suspension of the rules and passed the bill (25–0, 4 absent); it will be returned to the House for further consideration and any necessary signatures.

Why it matters: Sponsors said the measure helps close coverage gaps for diagnostic genetic testing that can be critical to treatment and long‑term care planning. The floor debate was brief and focused on definitions and who would be eligible for coverage; no opposing floor arguments were recorded.

Next steps: The bill returns to the House for final steps required by the legislative process.